Energi Holdings to Acquire 51% Stake in VivoPower's Tembo Subsidiary for $200M Enterprise Valuation

IQVIA and Veeva Systems have entered into long-term partnerships for clinical and commercial operations. The agreements enable mutual usage of data and software, enhancing efficiency and effectiveness for clients worldwide. Pending legal disputes have been resolved, and Veeva's data can now be utilized within IQVIA's commercial products, while IQVIA joins Veeva's Technology, AI, and Services Partner Programs. The partnerships are expected to deliver significant value to shared customers by integrating products and services seamlessly.

Title: IQVIA and Veeva Systems Form Long-term Clinical and Commercial Partnerships

IQVIA (NYSE: IQV) and Veeva Systems (NYSE: VEEV) have entered into long-term partnerships aimed at enhancing clinical and commercial operations. The agreements, which resolve all pending legal disputes, allow for the mutual use of data and software, thereby improving efficiency and effectiveness for clients worldwide.

Under the terms of the partnership, customers can now seamlessly integrate software, data, technology, and service offerings from both companies. In the commercial domain, IQVIA has joined Veeva's Technology, AI, and Services Partner Programs, enabling the use of Veeva data within IQVIA's commercial products and services. This includes the use of IQVIA data in Veeva Network for master data management (MDM), Veeva Nitro for analytics, and Veeva AI applications [1].

On the clinical side, IQVIA has joined Veeva's CRO Clinical Data Partner program, allowing for the execution of clinical trials using Veeva's software products, including study builds with Veeva EDC. This collaboration is expected to accelerate database builds, study locks, and data delivery, reducing critical timeframes in clinical development [2].

Both companies expressed their commitment to supporting frictionless product and services integration, with Veeva founder and CEO Peter Gassner stating, "We are committed to supporting frictionless product and services integration with IQVIA for the benefit of our joint customers and the industry overall" [1]. IQVIA chairman and CEO Ari Bousbib added, "IQVIA and Veeva's partnerships bring together best-in-class capabilities in information, AI, technology, and services for our shared clients" [1].

The partnerships are expected to deliver significant value to shared customers by integrating products and services seamlessly. This synergy is poised to eliminate prior technical and legal complexities, offering a frictionless experience for life sciences organizations aiming to deploy both companies' solutions together.

References:
1. [https://www.prnewswire.com/news-releases/iqvia-and-veeva-announce-long-term-clinical-and-commercial-partnerships-and-resolution-of-all-disputes-302531711.html](https://www.prnewswire.com/news-releases/iqvia-and-veeva-announce-long-term-clinical-and-commercial-partnerships-and-resolution-of-all-disputes-302531711.html)
2. [https://www.nasdaq.com/articles/iqvia-and-veeva-announce-long-term-clinical-and-commercial-partnerships](https://www.nasdaq.com/articles/iqvia-and-veeva-announce-long-term-clinical-and-commercial-partnerships)